About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical firm dedicated to revolutionizing the treatment of central nervous system (CNS) disorders. Our mission is to bridge critical gaps in patient care through innovative, differentiated products that target novel mechanisms of action. With an impressive neuroscience portfolio including FDA-approved therapies for major depressive disorder, excessive daytime sleepiness tied to narcolepsy and obstructive sleep apnea, as well as migraine, we are committed to improving outcomes for over 150 million individuals affected by serious neurological and psychiatric conditions in the United States. Explore more about our innovative solutions and our commitment to patient well-being on our website www.axsome.com.

